P1074: PROGNOSIS ANALYSIS AND A NEW RISK MODEL FOR RELAPSED AND REFRACTORY HODGKIN LYMPHOMA PATIENTS TREATED BY ANTI-PD-1: A REAL-WORLD MULTICENTER RETROSPECTIVE STUDY OF PATIENTS IN CHINA

Bibliographic Details
Main Authors: Wenyan Yu, Mei Geng, Jie Hao, Zeying Yan, Jian-Qing MI
Format: Article
Language:English
Published: Wiley 2023-08-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/01.HS9.0000971192.89168.b4
_version_ 1827331827422986240
author Wenyan Yu
Mei Geng
Jie Hao
Zeying Yan
Jian-Qing MI
author_facet Wenyan Yu
Mei Geng
Jie Hao
Zeying Yan
Jian-Qing MI
author_sort Wenyan Yu
collection DOAJ
first_indexed 2024-03-07T16:46:56Z
format Article
id doaj.art-214e4450405c4919b7c2794dee89d9b8
institution Directory Open Access Journal
issn 2572-9241
language English
last_indexed 2024-03-07T16:46:56Z
publishDate 2023-08-01
publisher Wiley
record_format Article
series HemaSphere
spelling doaj.art-214e4450405c4919b7c2794dee89d9b82024-03-03T06:25:13ZengWileyHemaSphere2572-92412023-08-017e89168b410.1097/01.HS9.0000971192.89168.b4202308003-00972P1074: PROGNOSIS ANALYSIS AND A NEW RISK MODEL FOR RELAPSED AND REFRACTORY HODGKIN LYMPHOMA PATIENTS TREATED BY ANTI-PD-1: A REAL-WORLD MULTICENTER RETROSPECTIVE STUDY OF PATIENTS IN CHINAWenyan Yu0Mei Geng1Jie Hao2Zeying Yan3Jian-Qing MI41 Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China2 Department of Oncology, Rui Jin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China3 Department of Hematology, Shanghai North Station Hospital4 Department of Hematology, Rui Jin North Medical Center Affiliated to Shanghai Jiao Tong University School of Medicine5 Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicinehttp://journals.lww.com/10.1097/01.HS9.0000971192.89168.b4
spellingShingle Wenyan Yu
Mei Geng
Jie Hao
Zeying Yan
Jian-Qing MI
P1074: PROGNOSIS ANALYSIS AND A NEW RISK MODEL FOR RELAPSED AND REFRACTORY HODGKIN LYMPHOMA PATIENTS TREATED BY ANTI-PD-1: A REAL-WORLD MULTICENTER RETROSPECTIVE STUDY OF PATIENTS IN CHINA
HemaSphere
title P1074: PROGNOSIS ANALYSIS AND A NEW RISK MODEL FOR RELAPSED AND REFRACTORY HODGKIN LYMPHOMA PATIENTS TREATED BY ANTI-PD-1: A REAL-WORLD MULTICENTER RETROSPECTIVE STUDY OF PATIENTS IN CHINA
title_full P1074: PROGNOSIS ANALYSIS AND A NEW RISK MODEL FOR RELAPSED AND REFRACTORY HODGKIN LYMPHOMA PATIENTS TREATED BY ANTI-PD-1: A REAL-WORLD MULTICENTER RETROSPECTIVE STUDY OF PATIENTS IN CHINA
title_fullStr P1074: PROGNOSIS ANALYSIS AND A NEW RISK MODEL FOR RELAPSED AND REFRACTORY HODGKIN LYMPHOMA PATIENTS TREATED BY ANTI-PD-1: A REAL-WORLD MULTICENTER RETROSPECTIVE STUDY OF PATIENTS IN CHINA
title_full_unstemmed P1074: PROGNOSIS ANALYSIS AND A NEW RISK MODEL FOR RELAPSED AND REFRACTORY HODGKIN LYMPHOMA PATIENTS TREATED BY ANTI-PD-1: A REAL-WORLD MULTICENTER RETROSPECTIVE STUDY OF PATIENTS IN CHINA
title_short P1074: PROGNOSIS ANALYSIS AND A NEW RISK MODEL FOR RELAPSED AND REFRACTORY HODGKIN LYMPHOMA PATIENTS TREATED BY ANTI-PD-1: A REAL-WORLD MULTICENTER RETROSPECTIVE STUDY OF PATIENTS IN CHINA
title_sort p1074 prognosis analysis and a new risk model for relapsed and refractory hodgkin lymphoma patients treated by anti pd 1 a real world multicenter retrospective study of patients in china
url http://journals.lww.com/10.1097/01.HS9.0000971192.89168.b4
work_keys_str_mv AT wenyanyu p1074prognosisanalysisandanewriskmodelforrelapsedandrefractoryhodgkinlymphomapatientstreatedbyantipd1arealworldmulticenterretrospectivestudyofpatientsinchina
AT meigeng p1074prognosisanalysisandanewriskmodelforrelapsedandrefractoryhodgkinlymphomapatientstreatedbyantipd1arealworldmulticenterretrospectivestudyofpatientsinchina
AT jiehao p1074prognosisanalysisandanewriskmodelforrelapsedandrefractoryhodgkinlymphomapatientstreatedbyantipd1arealworldmulticenterretrospectivestudyofpatientsinchina
AT zeyingyan p1074prognosisanalysisandanewriskmodelforrelapsedandrefractoryhodgkinlymphomapatientstreatedbyantipd1arealworldmulticenterretrospectivestudyofpatientsinchina
AT jianqingmi p1074prognosisanalysisandanewriskmodelforrelapsedandrefractoryhodgkinlymphomapatientstreatedbyantipd1arealworldmulticenterretrospectivestudyofpatientsinchina